CD163 and gestational diabetes: Thus, HtrA1 may predict an inflammation status in healthy women at the first trimester of gestation but, if used with other first-trimester GDM markers, such as soluble CD163 (sCD163) [40], and associated with pre-pregnancy BMI, it may significantly increase the GDM prediction rate at the first trimester.